Tuberculosis in Maharashtra


Tag: Tuberculosis in Maharashtra

Emerging resistance to new anti-tuberculosis drug bedaquiline warrants urgent action Médecins Sans Frontières (MSF) Policy Brief

Background: Tuberculosis is one of the leading causes of death worldwide and the main cause of mortality from a single infectious agent. In 2019 alone, approximately 1.4 million people died, and 465,000 fell ill with drug-resistant TB (DR-TB), a complex...

Read more

endTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India

Pune, India: Doctors Without Borders/ Médecins Sans Frontières (MSF) in collaboration with Indian Council for Medical Research (ICMR)- National AIDS Research Institute (NARI) and Department of Health Service, Government of Maharashtra is initiating two major clinical trials that aim at generating clinical evidence...

Read more

Providing medical care for drug-resistant tuberculosis in Mumbai

What We Do MSF provides free, comprehensive and individualized treatment at its independent clinic in Mumbai to people with severe forms of Drug resistant Tuberculosis (DRTB). Patients seen by MSF have previously been treated with ineffective regimens for several years by public and private...

Read more

Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai

Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF   For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB).  Pooja,...

Read more

India: Renewed hope with new drugs

Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons